Bill Commons

NY A 10428

in committee

Relates to the dispensing of certain prescriptions

New York · 2025-2026 Regular Session · lower

Quick answers

Did NY A 10428 pass?

Not yet. NY A 10428 is in committee as of 2026-03-06 and has not come to a final vote. Latest recorded action (2026-03-06): REFERRED TO HIGHER EDUCATION

What is NY A 10428 about?

Provides that mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label.

Who sponsors NY A 10428?

Karines Reyes is the primary sponsor of NY A 10428, joined by 14 cosponsors.

Description

Provides that mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label.

Introduced
Latest action
2026-03-06 — REFERRED TO HIGHER EDUCATION
Bill type
bill
Last updated

Sponsors

  • Karines Reyesprimary
  • Jenifer Rajkumarcosponsor
  • Amy Paulincosponsor
  • Tony Simonecosponsor
  • Yudelka Tapiacosponsor
  • Rebecca Seawrightcosponsor
  • Andrew Hevesicosponsor
  • Jo Anne Simoncosponsor
  • MaryJane Shimskycosponsor
  • Deborah Glickcosponsor
  • Steven Otiscosponsor
  • Linda Rosenthalcosponsor
  • Chris Burdickcosponsor
  • Alex Borescosponsor
  • Steven Ragacosponsor

Committees

Not provided by source.

Action timeline

  1. 2026-03-06

    REFERRED TO HIGHER EDUCATION

    referral-committee

Versions

Documents

Votes

Not provided by source.

Related bills

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z

Inspect retained evidence for changes recorded after evidence tracking began:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=A 10428. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.